Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a new study.

Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Inhibition of GSK-3β may inhibit tumor growth and improve survival through several complimentary mechanisms that include enhancement of chemotherapy activity, activation of innate anti-tumor immunity, ...

TFS HealthScience expands collaboration with Oncomatryx for phase Ib trial of OMTX705 for pancreatic cancer: Lund, S.E. Wednesday, May 7, 2025, 18:00 Hrs [IST] TFS HealthScience ( ...

Theriva Biologics Inc.’s stroma-targeting oncolytic virus approach yielded positive findings in metastatic pancreatic ductal adenocarcinoma, with the top-line readout of phase IIb data showing VCN-01 ...

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index.

The research, published in the journal Gut, focused on Porphyromonas gingivalis, a bacterium well known for causing gum ...